Want to see LUCY full AI Analyst Report?
LUCY Stock Chart & Stats
$1.06
-$0.56(-8.95%)
At close: 4:00 PM EST
$1.06
-$0.56(-8.95%)
Day’s Range― - ―
52-Week Range$0.66 - $2.30
Previous CloseN/A
Volume41.13K
Average Volume (3M)543.31K
Market Cap
$6.85M
Enterprise Value-$893.70K
Total Cash (Recent Filing)$5.68M
Total Debt (Recent Filing)$52.61K
Price to Earnings (P/E)―
Beta2.54
Next Earnings
Aug 13, 2026EPS Estimate
-0.37Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.75
Shares Outstanding6,403,728
10 Day Avg. Volume196,778
30 Day Avg. Volume543,314
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.44
Price to Sales (P/S)1.49
P/FCF Ratio-0.53
Enterprise Value/Market Cap-0.13
Enterprise Value/Revenue-0.30
Enterprise Value/Gross Profit-1.71
Enterprise Value/Ebitda0.11
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering1
EPS Forecast (FY)-1.45
Revenue Forecast (FY)$7.20M
Bulls Say, Bears Say
Bulls Say
Retail Distribution ExpansionA national retail rollout with FYihealth and affiliated optical brands meaningfully expands physical distribution into Canada and select U.S. provinces. This durable channel access increases recurring prescription replacement opportunities, strengthens retail partnership capabilities, and supports scaled product adoption over quarters.
Multi-year Revenue GrowthConsistent multi-year top-line expansion reflects improving product-market fit and accelerating customer adoption. Steady revenue growth provides a runway to absorb fixed costs, improve operating leverage over time, and justify incremental investment in product development and retail expansion across the 2–6 month horizon and beyond.
Low Leverage / Balance Sheet BufferA lightly levered balance sheet gives the company financial flexibility to fund inventory, retail rollout, or R&D without immediate refinancing pressure. Low debt reduces default risk and preserves strategic optionality for partnerships or opportunistic investments as the business scales distribution and product lines.
Bears Say
Persistent Operating And Net LossesDespite revenue gains, ongoing large operating and net losses show the business has not achieved profitable scale; this structurally constrains free cash generation and forces reliance on external capital or dilution to sustain growth, creating lasting pressure on returns and strategic options.
Volatile Cash GenerationA sharp TTM cash-flow reversal after multi-year cash burn suggests working-capital or one-off effects rather than steady operational cash generation. This volatility weakens confidence in sustainable cash flows, complicates planning, and increases the probability of future external financing needs within months.
Balance Sheet Data Inconsistency & Weak ReturnsMaterial inconsistencies in reported balance-sheet figures reduce comparability and raise scrutiny over financial reliability. Coupled with persistently negative ROE, this points to weak capital efficiency and governance risks that can hinder investor confidence and strategic execution over the medium term.
Innovative Eyewear, Inc. News
LUCY FAQ
What was Innovative Eyewear, Inc.’s price range in the past 12 months?
Innovative Eyewear, Inc. lowest stock price was $0.66 and its highest was $2.30 in the past 12 months.
What is Innovative Eyewear, Inc.’s market cap?
Innovative Eyewear, Inc.’s market cap is $6.85M.
When is Innovative Eyewear, Inc.’s upcoming earnings report date?
Innovative Eyewear, Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 34 days.
How were Innovative Eyewear, Inc.’s earnings last quarter?
Innovative Eyewear, Inc. released its earnings results on May 14, 2026. The company reported -$0.37 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.37.
Is Innovative Eyewear, Inc. overvalued?
According to Wall Street analysts Innovative Eyewear, Inc.’s price is currently Overvalued.
Does Innovative Eyewear, Inc. pay dividends?
Innovative Eyewear, Inc. does not currently pay dividends.
What is Innovative Eyewear, Inc.’s EPS estimate?
Innovative Eyewear, Inc.’s EPS estimate is -0.37.
How many shares outstanding does Innovative Eyewear, Inc. have?
Innovative Eyewear, Inc. has 6,403,728 shares outstanding.
What happened to Innovative Eyewear, Inc.’s price movement after its last earnings report?
Innovative Eyewear, Inc. reported an EPS of -$0.37 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -7.921%.
Which hedge fund is a major shareholder of Innovative Eyewear, Inc.?
Currently, no hedge funds are holding shares in LUCY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Innovative Eyewear, Inc.
Lucyd, Inc develops and sells smart eyewear in North America. It offers smart eyewear products to enable wearer to listen to music, take and make calls, and use voice assistants and ChatGPT to perform smartphone tasks hands-free, as well as prescription eyeglasses, ready-to-wear sunglasses, safety glasses, and sport glasses under the Lucyd Lyte, Lucyd Armor, Nautica, Eddie Bauer, and Reebok brand names. The company also provides Lucyd app for unlimited ChatGPT interactions and tech support. It sells its products through e-commerce and a network of retail stores of resellers. The company was formerly known as Innovative Eyewear, Inc. and changed its name to Lucyd, Inc in October 2025. Lucyd, Inc was founded in 2019 and is headquartered in North Miami, Florida.
LUCY Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Retractable Technologies
―
Staar Surgical
―
Warby Parker
―
―
Bausch + Lomb Corporation
―
Ownership Overview
0.46% Insiders
0.38% Mutual Funds
1.87% Other Institutional Investors
97.30% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---